Gel-forming mucins are major contributors to the viscoelastic properties of mucus secretion. Currently, four gel-forming mucin genes have been identified: MUC2, MUC5AC, MUC5B, and MUC6. All these genes have five major cysteine rich domains (four von Willebrand Factor (vWF) C or D domains and one Cystine-knot (CT) domain)
RNA Isolation and northern Blot Hybridization
RNA was isolated from human and mouse tissues by a single-step acid guanidinium thiocyanate phenol-chloroform extraction method (20) . For northern blot hybridization, equal amounts of total RNA (20 µg/lane) were subjected to electrophoresis on a 1.2% agarose gel in the presence of 2.2 M formaldehyde and then transblotted onto Nytran membranes. The RNA was cross-linked to membrane by a UV Stratalinker 2400 (Stratagene, La Jolla, CA). The clones corresponding to the 3' end sequence of MUC19/Muc19 were labeled with 32 P-dCTP by ready-to-go TM kit (Amersham Biosciences Corporation. Piscataway, NJ). After hybridization, all the blots were exposed overnight to the phosphor screen and read by the STORM TM system (Molecular Dynamics, Sunyvale, CA) (21) . The integrity of the RNA sample was verified by visualization of ribosomal 18S and 28S bands in the ethidium bromide stained gel. Table. 2) were further multiplied by a factor (10,000). The tissue with the value that is less than 0.01 has undetectable MUC19/Muc19 expression using this PCR method.
Expression Analysis by quantitative RT-PCR

SYBR
In Situ Hybridization
Glass slide sections from various tissue blocks were hybridized in the hybridization solution using biotin-labeled antisense or sense probes synthesized by in vitro transcription of MUC19/Muc19 clones. In situ hybridization was carried out as per the manufacturer's protocol (Roche Diagnostics Corporation, Indianapolis, IN) and modified as described before (21) . Briefly, slide sections were treated with 10 µg/ml Proteinase K in 50 mM Tris-Cl (pH 8.0) and 50 mM ethylenediamenetetraacetic acid for 15 min at Denhardt's solution, 10% dextran sulfate, 50 mM phosphate buffer (pH 7.0), 50 mM dithiothreitol, 250 µg/ml yeast transfer RNA, 100 µg/ml poly A, and 500 µg/ml salmonsperm DNA. The section was hybridized at 45°C overnight in a humidified chamber.
After hybridization, the section was washed twice for 15 min each time at 37°C with 2× SSC, twice for 15 min each time with 1× SSC, and twice for 15 min each time with 0.25× SSC. After the wash, the slide was reacted with anti-biotin primary antibody conjugated with alkaline phosphatase. After several washes, the reacted probes in the slide were color-developed with the Biotin Nucleic Acid Detection kit from Roche Diagnostics Corporation (Indianapolis, IN).
Results:
Developing "Hidden Markov Model" for the genome-wide search of new gel-
forming mucin genes
In order to conduct a genome-wide search for new gel-forming mucin genes, a specific "Hidden Markov Model" was developed based on the sequence alignment of all known gel-forming mucins (Fig.1) . To enhance the representation of this model, sequences from species other than human and mouse were also included in the alignment.
Using this finalized model, a comprehensive search of the human and mouse EST databases revealed many hits with high scores, especially those from the mouse EST databases. Most of these hits were parts of the known gel-forming mucin genes (MUC2/Muc2, MUC5AC/Muc5AC, etc.). Because of significant high score of these hits in the mouse EST database, we decided to focus on the mouse gene. After processing those results by an in-house program, 24 mouse ESTs that didn't match any known mouse mucin gene, were obtained from the search. These ESTs were in fact generated from the same gene. The translated product of this new gene has a bona fide gel-forming mucin like CT domain (Fig.2Ab ).
Molecular cloning and sequence characterization of the 3' end of novel gel-forming mucin gene, Muc19.
We then carried out 5'/3' RACE using the primers deduced from the potential coding region of this new gene. The total mouse salivary gland RNA was used because all the ESTs from this new gene were obtained from mouse salivary gland library SG2. For 5'RACE, we used mmuc19_1740 as gene specific primer; for 3' RACE, we used mmuc19_1392. Sequences of the primers are listed in the Table. 1. By these methods, we were able to obtain two cDNA clones (1.897 kb and 2.023 kb) that were generated by different polyadenlynation sites (Fig.2Aa) . The longer transcript has the same ORF as the shorter one, but has longer 3' UTR. The sequence has been deposited into GenBank under the accession number AY193891. The deduced peptide sequence has significantly high threonine and serine content (35.9%) and several mucin-like threonine/serine-repeats (Fig.2Ac) . It also has the signature motifs of gel-forming mucin: VWC and CT domains (Fig.2Ab) . Since mucins are named numerically in chronological order, we therefore named this new mouse mucin gene as Muc19. By comparing the Muc19 sequence with the UCSC and NCBI human genome sequence database, the cloned 3' end sequences of Muc19 was found to reside at chromosome 15 ( Fig.3A) and consists of 9 exons (Fig.2Aa) .
Identification of the human MUC19 locus by searching the translated genomic database with "gel-forming mucin Hidden Markov Model"
In contrast to mouse EST database search, the human MUC19 was not found in the human EST library. After looking through the current human EST libraries, we realized this problem might be due to the lack of the human salivary gland library in the human EST database. To overcome this obstacle, we carried out the screening using the translated human genomic databases deduced from the publicly available GenBank database. By using this approach, we were able to identify the putative human MUC19 locus in chromosome 12. (Fig.3B) We also screened the translated mouse genomic databases and found the mouse Muc19 locus at chromosome 15 ( Fig.3B ), which further confirmed the sensitivity and accuracy of our screening method. Interestingly, this portion of mouse chromosome 15
seems to be the homologous region to the human chromosome 12.
Notably, we were unable to identify other candidate than MUC19/Muc19 by this search on both human and mouse genomes.
Molecular cloning and sequencing of the 3' end of human MUC19
In order to clone the human MUC19, we designed various primers corresponding to the deduced cDNA region of the MUC19 locus. RT-PCR and 5'/3' RACE were used to amplify MUC19 cDNA from human salivary gland RNA. For 5'RACE, we used primerhmuc19_2021; for 3' RACE, we used hmuc19_1878. We further used the hmuc19_1110/ hmuc19_2021 primer pair to confirm the sequence by RT-PCR. All the primer sequences are listed in Table. 1. Using these approaches, we cloned and sequenced a 2.23 kb MUC19
cDNA fragment ( Fig.2B ) (GenBank accession: AY236870). The deduced peptide sequence also has very high threonine and serine content (31.4%) and many mucin-like threonine/serine repeats (Fig.2Bc ). VWC and CT domains were also identified in the sequence (Fig.2Bb) . Interestingly, we did not find an alternative polyadenylation site in the human sample (Fig.2Ba ). The cloning of MUC19 from human salivary gland tissue demonstrates the similarity of the expression between human and mouse clones in terms of tissue specificity.
Phylogenetic and sequence analysis of gel-forming mucin genes
Phylogenetic analysis of various gel-forming mucin genes and vWF from different species indicates that MUC19 belongs to the PSM/BSM cluster ( . It also appears that MUC19 is much more similar to PSM than Muc19 (Fig.5) . Notably, the similarities among those three sequences are particularly high within the last 250AA of the C-terminus, where the CT domain resides. CT domains have been shown to play a crucial role in dimer formation (4, 5). It appears that the mucin repeat regions are very diversified even among the homologues in different species, which is also true for other gel-forming mucins. The only common feature of those mucin repeats is that they are all threonine/serine rich and contain potential sites for O-glycosylation.
The predicted gene structure upstream of the cloned 3' end of MUC19/Muc19
The genomic sequences from both the human MUC19 and mouse Muc19 locus allow us to deduce the genomic structure and protein motifs. Most importantly, those sequences have been shown to be very similar to PSM. We then tried to predict the gene structure upstream of the cloned MUC19/Muc19 sequences by comparing their genomic sequence with PSM peptide sequence using Genewise program (Ewan Birney http://www.sanger.ac.uk/Software/Wise2). The benefit of this prediction program is that it utilizes sequence homology in addition to sequence statistics to facilitate the exon prediction. Thus it is more accurate than the conventional exon prediction method like GENESCAN that is solely dependent on sequence statistics (19) . As shown in Fig.6 (A-B), both peptide sequences deduced from the genomic sequences share similar structural domains with other gel-forming mucin genes: 5'-VWD-VWD-VWD-mucin repeats-VWC-CT-3'. Both genes seem to have a very large central region containing most of the serine/threonine-rich repeats, which is reminiscent of the large central exon of MUC5B gene (22) . Those structural features are very similar to PSM (Fig.6C) . As we expected, the predicted peptide sequences from MUC19 and Muc19 were very similar with PSM sequence (Fig.7) . Highly homologous sequences were found at both the C terminus and putative N terminus of the peptide sequences of MUC19/Muc19, while no significant homology was seen in the central repetitive regions (Fig.7) . Both MUC19 and Muc19 are very large genes. Human MUC19 has more than 180kb of genomic sequence with a deduced peptide sequence larger than 7000 amino acids, while mouse Muc19 has about 80 kb of genomic sequences with about 3000 amino acids. The smaller size of mouse Muc19 might result from more gaps and much lower quality of the mouse genomic sequences available in the current database. We expect that the genomic size of mouse
Muc19 is probably similar to human MUC19 when the mouse genomic project is complete.
Characterization of the expression of MUC19/Muc19 in vitro and in vivo
In order to further examine the expression of MUC19/Muc19 in various tissues, both northern blot and RT-PCR approaches were used to screen the mouse and human multitissue panels. Like other gel forming mucin gene messages, the northern blot revealed a polydispersed feature of MUC19/Muc19 message in salivary gland and tracheal tissues (Fig.8A) . In mouse, Muc19 is mainly expressed in the two major salivary glands, sublingual and submandibular, an to a much less extent, in trachea (Fig.8A) . Muc19 is expressed at a higher level in the sublingual gland than that in the submandibular gland, while undetectable in the parotid gland (Fig.8A ). This result is consistent with the distribution of mucous cell population in those glands. In these three major salivary glands, the sublingual gland contains mostly the mucous cell type, the submandibular gland contains a mixture of mucous and serous cell types, while the parotid gland cells are mostly the serous cell type. In human tissues, we also detected similar polydispersed signals from trachea and submandibular gland RNA samples (Fig.8B) . In order to increase the sensitivity and the coverage of this tissue distribution study, we further used the quantitative RT-PCR method to screen additional human and mouse tissue samples.
In the screening, primers-hmuc19_1333/hmuc19_1426 were used for human, and primers-mmuc19_1378/mmuc19_1443 were used for mouse. As summarized in Table 2 , MUC19/Muc19 expression is very restricted and cannot be detected by RT-PCR in various non-glandular tissues.
We used in situ hybridization to further examine the specific cell types that express MUC19/Muc19 messages. MUC19 transcripts were detected in the mucous cells of the submandibular gland and submucosal gland of the trachea from human (Fig.9) . A similar positive hybridization of mouse Muc19 probe was seen in mouse tissue sections from the sublingual gland and tracheal submucosal gland (Fig.10) . Notably, there is no hybridization signal in most serous cells of these glands. The strict cell type specificity of MUC19/Muc19 may explain why low levels of these transcripts in the tracheal RNA sample in which most of the RNA species are generated from the non-glandular portion.
Discussion:
The current explosion of sequence data from the genome project and EST project of different species make it much easier to identify new gene family members. In addition to the simple sequence similarity search, pattern-based search methods have proven to be more robust (13, 17) . In this study, we successfully utilized the "Hidden Markov Model" based approach to identify a novel gel-forming mucin gene, MUC19/Muc19, which are specifically expressed in various glandular tissues.
In contrast to conventional biological discovery, the bioinformatic discovery approach requires a precise mathematical definition of the specific feature of the gene family of interest. Our initial attempt to define the "mucin-like threonine/serine rich repeats" for discovering new mucin genes was a complete failure. This was partly due to the heterogeneous nature of the mucin genes; some of them are named quite arbitrarily.
MUC7, for example, was named as mucin only because of the presence of four mucinlike serine/threonine rich repeats (23) . As a matter of fact, many immunoglobulin genes have more mucin repeats than MUC7. It seems that the conventional mucin definition is too loose to distinguish the real mucins from other mucin-like genes. Thus, we tried to define the mucin genes based on additional features of their peptide sequences. We found that a mucin subgroup called "gel-forming mucin" (1, 12) was much easier to be defined.
All of these gel-forming mucin genes share similar conserved motifs and structures. Most notably, they have been suggested to be the determining factor for the viscoelastic properties of mucus secretion and mucus gel formation in various organs. We therefore defined the "gel-forming mucin-specific Hidden Markov model" based on specific features at the 3' ends of known gel-forming mucin genes in various species. After screening the ESTs databases, we found this "gel-forming mucin-specific Hidden
Markov model" to be very specific and discriminating. The approach identified all previously known gel-forming mucin genes of various species without missing any. No other hits had a high enough score to be considered except MUC19/Muc19. That was also true when translated human and mouse genomic databases were included for the screening.
The newly identified MUC19/Muc19 gene has the gel-forming mucin feature with a structure significantly similar to the porcine and bovine submaxillary mucins. It has been suggested that all the known gel-forming mucin genes are evolved from one common ancestor with vWF by gene duplication events (1) . Structurally, MUC19/Muc19 are also very similar to vWF as well as other gel-forming mucin genes. Interestingly, human MUC19 resides in chromosome 12q12, which is close to the location of vWF (12p13). In the phylogenetic tree, MUC19 is much closer to the MUC2/MUC5AC/MUC5B than MUC6, although MUC6 is also located in the 11p15 (24) . We suspect that MUC19 shares a similar ancestor with the other gel-forming mucins and branched out evolutionarily later than MUC6.
The most striking feature of MUC19/Muc19 is their size. Of the known sequences, MUC5B is the largest human gel-forming mucin consisting of ~5000 amino acids (21, 22, 25) . However, newly identified human MUC19 has more than 7000 amino acids based on the known sequence. Considering that there are gaps in the sequence and its porcine counterpart has 13288 amino acids (26) The identical amino acids are marked by shade. 
